Across TCGA pan-cancer cohorts, SNRPGP9 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated SNRPGP9 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SNRPGP9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNRPGP9 expression acts as an unfavorable survival marker, although some lineages such as THCA and THYM show a favorable association.

ACC, UCEC, and KICH are the cancer types where SNRPGP9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	II,III,IV	0.527	0.864	<.001	79	view →
UCEC	DFS	Median	All	0.553	0.724	<.001	70	view →
KICH	OS	Median	II,III,IV	0.665	0.960	.008	55	view →
BRCA	DFS	Median	II,III,IV	0.919	0.962	.001	41	view →
STAD	OS	Tertile	All	0.373	0.628	.009	38	view →
MESO	OS	Tertile	IV	0.287	0.815	.005	34	view →
SKCM	DFS	Median	II,III,IV	0.595	0.811	<.001	22	view →
UVM	DFS	Quartile	All	0.256	0.846	<.001	21	view →
LIHC	OS	Quartile	All	0.672	0.856	.004	20	view →
KIRP	DFS	Tertile	IV	0.036	0.529	.010	19	view →
THCA	DFS	Quartile	All	0.964	0.807	.013	19	view →
THYM	DFS	Quartile	All	0.913	0.526	.007	19	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

Exploration

Same gene, other analysis: SNRPGP9 tumor-vs-normal RNA expression · all SNRPGP9 data types